PCM
ADAP

Penserra Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Penserra Capital Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,135
Closed -$16K – 1344
2021
Q3 		$16K Buy
3,135
+30
+1% +$153 ﹤0.01% 1279
2021
Q2 		$13K Buy
3,105
+5
+0.2% +$21 ﹤0.01% 1248
2021
Q1 		$16K Sell
3,100
-80
-3% -$413 ﹤0.01% 990
2020
Q4 		$17K Buy
+3,180
New +$17K ﹤0.01% 865